P533: SINGLE-CENTER PHASE 2 STUDY OF PD-1 INHIBITOR COMBINED WITH DNA DEMETHYLATION AGENT + CAG REGIMEN IN PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA: INTERIM ANALYSIS

Authors: X.-N. Gao, Y.-F. Su, Y. Jing, J. Wang, L. Xu, L.-L. Zhang, A. Wang, Y.-Z. Wang, Y.-F. Li, D.-H. Liu

Published: 2022-06-23

DOI: 10.1097/01.hs9.0000845020.97630.e7

Source: Full article


Abstract

No abstract found.